Syndax Pharmaceuticals, Inc. Public Float
Syndax Pharmaceuticals, Inc. (SNDX) had Public Float of $799.20 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $799.20M.
- 2024-06-30: Entity Public Float $1.70B.
- 2023-06-30: Entity Public Float $1.45T.
- 2022-06-30: Entity Public Float $1.08B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $799.20M 10-K · filed 2026-02-26 |
| 2024-06-30 | $1.70B 10-K · filed 2025-03-03 |
| 2023-06-30 | $1.45T 10-K · filed 2024-02-27 |
| 2022-06-30 | $1.08B 10-K · filed 2023-02-28 |
| 2021-06-30 | $833.40M 10-K · filed 2022-03-01 |
| 2020-06-30 | $500.10M 10-K/A · filed 2021-04-30 |
| 2019-06-30 | $208.30M 10-K · filed 2020-03-05 |
| 2018-06-30 | $118.00M 10-K · filed 2019-03-07 |
| 2017-06-30 | $117.10M 10-K · filed 2018-03-08 |
| 2016-06-30 | $109.60M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |